BSECompany Update8 Sept 2026 · 8 Sept 2026, 07:46 pm

Investor Meet Intimation

Gland Pharma Ltd · 543245

✦ AI Summary

Gland Pharma Ltd has announced a schedule of Analyst/Institutional Investor Meetings on September 11, 2026, with DSP Mutual Fund for a one-on-one meeting.

Analysis Scores

Earnings Impact1/10

Growth Catalyst1/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

54ad8654-1c3a-47c6-bb01-1c7e771b1b0d.pdf

pdf

Download →

View document text

September 08, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor 25th floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Bandra Mumbai - 400 001 (East), Mumbai - 400 051 Scrip Code: 543245 Symbol: GLAND (ISIN: INE068V01023) Dear Sir/Madam, Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; please find below the schedule of the Analyst/ Institutional Investor Meetings with the Company: Date Investor/Analyst/Fund Name Type of Meeting September 11, 2026 DSP Mutual Fund One-on-One Meeting The schedule of the above-mentioned meetings is subject to change, and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company. This is for your information and records. Yours truly, For Gland Pharma Limited Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer